BioCentury
ARTICLE | Company News

Alkermes, Recro deal

May 11, 2015 7:00 AM UTC

Recro completed its purchase of IV/IM meloxicam and its related business unit and manufacturing facility from Alkermes (see BioCentury, April 13). ...